AusperBio

Foster City, United States

AusperBio is a biotechnology company that develops innovative drugs for curing chronic hepatitis B and other major infectious diseases.

$63.0M raised

Sep 2025

Series B

Top Investors

Qiming Venture PartnersCDH InvestmentsBioVentureSherpa Healthcare PartnersGenesis Capital

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has AusperBio raised?

AusperBio has raised $63.0M in total funding. The most recent round was Series B. The last funding was announced in September 2025.

Who are AusperBio's investors?

AusperBio's investors include Qiming Venture Partners, CDH Investments, BioVenture, Sherpa Healthcare Partners, Genesis Capital.

Where is AusperBio headquartered?

AusperBio is headquartered in Foster City, United States.

What does AusperBio do?

AusperBio is a biotechnology company that develops innovative drugs for curing chronic hepatitis B and other major infectious diseases.

What stage is AusperBio at?

AusperBio is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 21, 2025.

MLA

"AusperBio — Funding & Investors." VCBacked, September 21, 2025, https://www.vcbacked.co/company/ausperbio. Accessed June 3, 2026.

APA

VCBacked. (2025). AusperBio — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/ausperbio

Wikipedia (cite web)

{{cite web |title=AusperBio — Funding & Investors |url=https://www.vcbacked.co/company/ausperbio |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 21, 2025.